Press:

August 4, 2016

ALCOR Scientific is First Rhode Island Company to do Business in Iran, Post-Sanctions

ALCOR Scientific is First Rhode Island Company to do Business in Iran, Post-Sanctions

ALCOR makes inroads into the Iranian healthcare market with the iSED – a highly accurate blood analyzer that allows laboratories to identify inflammation in patients in just 20 seconds

Smithfield, R.I. – August 4, 2016 – ALCOR Scientific today announced that it is the first Rhode Island-based company to do business in Iran in 15 years, following the lifting of international trade sanctions in January. With U.S.-Iran trade relations now open, ALCOR will be selling its iSED® Erythrocyte Sedimentation Rate Analyzer – a blood analyzer that identifies inflammation in patients – to Iranian hospitals and laboratories.

“ALCOR Scientific is proud to be contributing to Rhode Island’s economic development and exports. As an innovative young company with highly targeted, patented healthcare instruments and equipment, we’re looking forward to bringing the iSED to Iranian labs, physicians and patients,” said Carlo Ruggeri, CEO and founder of ALCOR Scientific. “As Iranian laboratories adopt the fully-automated iSED, physicians across several disciplines will be able to provide faster and more accurate diagnoses for patients. With sanctions now lifted, we are anticipating strong demand for the iSED from both hospital laboratories as well as from independent labs.”

Alcor Scientific’s expansion into the Iranian market was supported by the Chafee Center for International Business at Bryant University’s State Trade Enhancement Program (STEP), a federally funded program administered through the U.S. Small Business Administration. STEP makes matching-fund awards to states to assist small businesses in entering and expanding into international markets.

“The Chafee Center for International Business was pleased to be able to provide Alcor Scientific funding through STEP to help finance the cost of participating in international trade events, including participation in the Best of New England Pavilions at MEDICA and at Arab Health,” said Linda Woulfe, assistant director and STEP Manager at Bryant University’s Chafee Center for International Business.  With the help of this partnership, Alcor is also currently working with several distributors throughout the global healthcare industry.

The iSED is expected to achieve significant market penetration in Iran, and from this ALCOR plans to expand distribution of its other product lines into the Iranian market.

The iSED, the only fully-automated erythrocyte sedimentation rate analyzer manufactured in the U.S., analyzes red blood cells as a first line of diagnosis for multiple illnesses, as well as to patients’ responses to medications such as chemotherapy or steroids. It provides lab technicians with a result in just 20 seconds, compared with 30-60 minutes for older, less sophisticated systems.

In addition to Iran and North America, the iSED is available through distributors in Europe, Asia, Africa and South America.

“The success of Alcor Scientific is true testimony to the success of the STEP program and the potential for small businesses to succeed internationally.  Congratulations to Alcor Scientific in being a true pioneer and leading small business exporter!” Woulfe noted.

For more information, to place an order for the iSED, or to inquire about distribution opportunities in the US or abroad, contact ALCOR at 1-800-495-5270 or info@alcorscientific.com.

About ALCOR Scientific, Inc.

ALCOR Scientific is a designer and manufacturer of innovative diagnostic instrumentation and medical devices for the healthcare industry.  As a result of steady investment on research and development, the company is able to provide transformational solutions in a wide range of healthcare applications. Alcor blends creative thinking, a deep understanding of bioscience, and state-of-the-art manufacturing techniques to help healthcare providers improve patient care.

ALCOR Scientific products are sold directly and through a network of dealers to healthcare providers worldwide. All of Alcor’s products are designed and manufactured in the USA, at the Smithfield, Rhode Island location.

July 24, 2014

ALCOR Scientific Expands iSED® Analyzer to New Markets

ALCOR Scientific Expands iSED® Analyzer to New Markets

Advanced Technology Delivers Results in Seconds Using Small Sample Smithfield, Rhode Island, July 24, 2014 – ALCOR Scientific, a provider of in vitro diagnostic analyzers and medical devices for enteral nutrition delivery, announced it has expanded availability of its iSED® system for erythrocyte sedimentation rate (ESR) testing to new markets to meet growing demand for this advanced technology. Initially launched in the US in late 2012, the iSED is CE marked and now available through distributors in Europe, Asia, Africa, South America and North America.

The iSED provides fully automated ESR testing – one of the most widely used lab tests worldwide, yet historically one of the most time-consuming and cumbersome to perform. The iSED transforms ESR testing by employing patented technology that delivers accurate results in 20 seconds using a blood sample of just 100uL, which is ideal when working with pediatric and geriatric patients. The iSED has a throughput of up to 180 samples per hour, made possible by its random access, continuous feed operation.

The only fully automated ESR analyzer designed and manufactured in the US, the iSED tests samples directly from standard EDTA tubes, reducing both testing costs and contaminated waste. With its closed tube sampling and no disposables required, the iSED greatly speeds processes and improves efficiency and safety for lab clinicians. The iSED’s high degree of accuracy is enabled by the use of quantitative photometry to measure, in a perfectly controlled environment, the formation of the red cell aggregates (Rouleaux) in the most critical phase of the red cell sedimentation. This technology ensures the results obtained reflect the patient’s inflammation status so accurately, unaffected by variables such as mixing and temperature.

“The iSED’s rapid adoption is a testament to its ability to facilitate patient testing through a cost-effective and user-friendly solution that streamlines lab processes,” said Carlo Ruggeri, CEO and founder. “Alcor looks forward to introducing new, innovative diagnostic and medical device products driven by the same principles.”

The iSED will be featured at the ALCOR exhibit booth at the American Association of Clinical Chemistry (AACC) Annual Meeting and Expo in Chicago, Illinois, July 29-31. For more information, to place an order for the iSED, or to inquire about distribution opportunities, contact ALCOR at 1-800-495-5270 or info@alcorscientific.com.

About ALCOR Scientific, Inc.
ALCOR Scientific designs, develops and manufactures in vitro diagnostic analyzers and medical devices for enteral nutrition delivery, employing innovative, proprietary technologies. A privately held company based in Smithfield, Rhode Island, ALCOR has taken a leadership position in the in vitro diagnostic market with its advanced blood rheology analyzers that measure red blood cell sedimentation, aggregation and viscometry. The company is also a leading supplier of enteral feeding pumps worldwide.